Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-18-004464
Filing Date
2018-02-27
Accepted
2018-02-27 19:43:13
Documents
1
Period of Report
2018-02-24

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 9451
  Complete submission text file 0001225208-18-004464.txt   10849
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Issuer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Lewis-Hall Freda C (Reporting) CIK: 0001437909 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03619 | Film No.: 18647565